Скачать или смотреть BESREMi in Practice: Getting Started With Confidence

Please see ISI and full Prescribing Information, including Boxed Warning (https://bit.ly/3LJy5iW) for BESREMi.

This video is intended for US healthcare professionals only.

Dr. Edward Pearson, a hematologist who specializes in bone marrow and blood disorders such as polycythemia vera (PV), discusses his experiences and what to expect when starting treatment with BESREMi.

Watch as Dr. Pearson identifies patients who can benefit from BESREMi, shares titration techniques and monitoring advice, and highlights when to expect an initial response. He also dives into how this first-line treatment may reduce frequency of phlebotomies.

*Interferon alfa products may cause or aggravate fatal or life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should be monitored closely with periodic clinical and laboratory evaluations. Therapy should be withdrawn in patients with persistently severe or worsening signs or symptoms of these conditions. In many, but not all cases, these disorders resolve after stopping therapy.*

For more information, visit https://BESREMiHCP.com